PVP Ventures Ltd
Incorporated in 1991, PVP Ventures
Ltd develops urban infrastructure
and investments in various ventures[1]
- Market Cap ₹ 668 Cr.
- Current Price ₹ 25.7
- High / Low ₹ 39.3 / 20.1
- Stock P/E 150
- Book Value ₹ 8.13
- Dividend Yield 0.00 %
- ROCE -1.70 %
- ROE -2.14 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of 11.1% over last 3 years.
- Company's cost of borrowing seems high
- Working capital days have increased from 97,308 days to 2,92,639 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Realty Industry: Construction
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
47.77 | 63.47 | 53.36 | 18.52 | 37.67 | 28.39 | 30.45 | 29.00 | 17.53 | 32.21 | 159.97 | -0.04 | 0.00 | |
12.38 | 30.62 | 33.09 | 9.32 | 8.19 | 7.19 | 11.08 | 8.28 | 4.28 | 7.96 | 20.68 | 10.71 | 14.14 | |
Operating Profit | 35.39 | 32.85 | 20.27 | 9.20 | 29.48 | 21.20 | 19.37 | 20.72 | 13.25 | 24.25 | 139.29 | -10.75 | -14.14 |
OPM % | 74.08% | 51.76% | 37.99% | 49.68% | 78.26% | 74.67% | 63.61% | 71.45% | 75.58% | 75.29% | 87.07% | ||
10.60 | 0.22 | -0.06 | 12.51 | 0.67 | 0.35 | 7.59 | 0.22 | 0.52 | -497.85 | -68.57 | 44.17 | 15.16 | |
Interest | 0.44 | 19.44 | 19.67 | 19.61 | 19.41 | 20.45 | 24.87 | 29.18 | 27.81 | 28.18 | 7.62 | 4.90 | 3.38 |
Depreciation | 0.15 | 0.21 | 0.60 | 0.54 | 0.59 | 0.58 | 0.55 | 0.87 | 0.71 | 0.57 | 0.85 | 0.80 | 0.87 |
Profit before tax | 45.40 | 13.42 | -0.06 | 1.56 | 10.15 | 0.52 | 1.54 | -9.11 | -14.75 | -502.35 | 62.25 | 27.72 | -3.23 |
Tax % | 20.07% | 40.24% | -2,783.33% | 0.00% | -103.65% | 176.92% | 0.00% | 29.64% | 0.00% | 0.00% | 39.00% | -16.88% | |
36.29 | 8.02 | 1.61 | 1.56 | 20.67 | -0.40 | 1.53 | -11.81 | -14.75 | -502.34 | 37.97 | 32.39 | 4.49 | |
EPS in Rs | 1.48 | 0.33 | 0.07 | 0.06 | 0.84 | -0.02 | 0.06 | -0.48 | -0.60 | -20.50 | 1.55 | 1.24 | 0.18 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 5% |
3 Years: | 20% |
TTM: | 111% |
Stock Price CAGR | |
---|---|
10 Years: | 17% |
5 Years: | % |
3 Years: | 62% |
1 Year: | -20% |
Return on Equity | |
---|---|
10 Years: | 1% |
5 Years: | 2% |
3 Years: | 11% |
Last Year: | -2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 245.05 | 245.05 | 245.05 | 245.05 | 245.05 | 245.05 | 245.05 | 245.05 | 245.05 | 245.05 | 245.05 | 260.40 | 260.40 |
Reserves | 423.39 | 416.23 | 402.65 | 358.54 | 379.17 | 378.79 | 364.98 | 352.90 | 338.19 | -164.14 | -76.09 | -45.72 | -48.74 |
181.35 | 185.13 | 143.71 | 143.62 | 144.05 | 182.31 | 181.70 | 181.87 | 176.07 | 187.43 | 39.45 | 33.05 | 25.45 | |
215.16 | 183.63 | 157.32 | 160.75 | 150.06 | 111.06 | 119.57 | 128.56 | 142.90 | 142.25 | 82.75 | 100.89 | 133.74 | |
Total Liabilities | 1,064.95 | 1,030.04 | 948.73 | 907.96 | 918.33 | 917.21 | 911.30 | 908.38 | 902.21 | 410.59 | 291.16 | 348.62 | 370.85 |
77.32 | 63.58 | 47.88 | 1.90 | 2.69 | 2.27 | 2.46 | 2.28 | 3.00 | 2.45 | 2.66 | 1.81 | 3.41 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 499.24 | 497.20 | 280.14 | 820.12 | 821.99 | 823.19 | 820.79 | 824.12 | 815.48 | 331.85 | 229.75 | 30.73 | 26.10 |
488.39 | 469.26 | 620.71 | 85.94 | 93.65 | 91.75 | 88.05 | 81.98 | 83.73 | 76.29 | 58.75 | 316.08 | 341.34 | |
Total Assets | 1,064.95 | 1,030.04 | 948.73 | 907.96 | 918.33 | 917.21 | 911.30 | 908.38 | 902.21 | 410.59 | 291.16 | 348.62 | 370.85 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.40 | 12.23 | 93.06 | 0.82 | 3.58 | 5.00 | 4.63 | 5.62 | 1.58 | 0.03 | 182.36 | -0.57 | |
21.54 | 4.21 | -33.02 | -0.79 | -3.22 | -1.34 | -0.21 | -3.40 | 9.06 | -14.88 | -84.75 | 7.64 | |
-21.29 | -15.63 | -61.07 | -0.42 | 0.31 | -3.99 | -9.43 | -3.10 | -7.14 | 11.36 | -96.26 | -8.40 | |
Net Cash Flow | -0.15 | 0.81 | -1.03 | -0.40 | 0.67 | -0.32 | -5.01 | -0.88 | 3.50 | -3.49 | 1.35 | -1.34 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 13.60 | 14.38 | 20.66 | 61.29 | 60.37 | 88.84 | 17.26 | 16.24 | 32.07 | 2.83 | 0.00 | 0.00 |
Inventory Days | 0.00 | 0.00 | 0.00 | 13,673.61 | 12,279.77 | 16,515.62 | 16,067.30 | 23,735.95 | 8,591.96 | 1,649.93 | -466,105.00 | |
Days Payable | 73.40 | 141.23 | 173.69 | 194.67 | 167.90 | 103.30 | 22.61 | |||||
Cash Conversion Cycle | 13.60 | 14.38 | 20.66 | 13,661.51 | 12,198.91 | 16,430.77 | 17.26 | 15,888.87 | 23,600.12 | 8,491.49 | 1,627.32 | -466,105.00 |
Working Capital Days | -901.61 | -513.43 | -459.60 | -87.31 | -157.74 | -388.27 | -281.93 | -1,035.84 | -717.09 | -795.05 | 79.54 | 292,638.75 |
ROCE % | 4.26% | 3.93% | 2.46% | 2.30% | 3.90% | 2.67% | 2.40% | 2.56% | 1.70% | 4.74% | 58.14% | -1.70% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
2d - PVP acquires 52% stake in Biohygea, expanding into healthcare diagnostics in Tier 2/3 cities.
-
Announcement under Regulation 30 (LODR)-Updates on Acquisition
2d - PVP Ventures acquires 52% stake in Biohygea Global for Rs. 7 crore, making it a subsidiary.
-
Press Release
2d - PVP acquires 56% of Optimus Oncology for INR 55 Cr, plans 76% stake, expanding oncology services in Tier 2/3 cities.
-
Appointment of Company Secretary and Compliance Officer
2d - PVP Ventures to acquire 56% of Optimus Oncology for INR 55 crore; new Company Secretary appointed.
-
Announcement under Regulation 30 (LODR)-Acquisition
2d - PVP Ventures to acquire 56% of Optimus Oncology for INR 55 crore, expanding healthcare footprint.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
PVPVL is the holding company of the Hyderabad based PVP group, which has business interests in real estate, media & entertainment. The Group is engaged in developing urban infrastructure including residential projects, movie production and movie financing related activities.